XML 43 R32.htm IDEA: XBRL DOCUMENT v3.25.3
EQUITY (Tables)
 9 Months Ended
Sep. 30, 2025
Stockholders' Equity Note [Abstract]  
Schedule of Changes In Consolidated Equity
The following tables present the changes in consolidated equity (dollars in millions, share amounts in thousands):
Common StockAdditional
Paid-In
Capital		Accumulated
Other
Comprehensive
Loss		Retained EarningsTreasury
Stock		Noncontrolling
Interests		Total Equity
Shares
Outstanding		Issued Par
Amount
Balances at December 31, 202495,109 $8 $4,873 $(180)$3,008 $(3,538)$1,649 $5,820 
Net income— — — — 406 — 95 501 
Distributions paid to noncontrolling interests— — — — — — (89)(89)
Other comprehensive income— — — 2 — — — 2 
Net purchases (sales) of businesses and noncontrolling interests— — (35)— — — 41 6 
Repurchases of common stock(2,629)— — — — (351)— (351)
Stock-based compensation expense, tax benefit and issuance of common stock405 — (12)— — — — (12)
Balances at March 31, 202592,885 8 4,826 (178)3,414 (3,889)1,696 5,877 
Net income— — — — 288 — 105 393 
Distributions paid to noncontrolling interests— — — — — — (83)(83)
Other comprehensive income— — — 1 — — — 1 
Net purchases of businesses and noncontrolling interests— — 10 — — — 9 19 
Repurchases of common stock(4,601)— — — — (753)— (753)
Stock-based compensation expense, tax benefit and issuance of common stock60 — 22 — — — — 22 
Balances at June 30, 202588,344 8 4,858 (177)3,702 (4,642)1,727 5,476 
Net income— — — — 342 — 106 448 
Distributions paid to noncontrolling interests— — — — — — (102)(102)
Other comprehensive income— — — 3 — — — 3 
Purchases (sales) of businesses and noncontrolling interests, net— — (9)— — — 38 29 
Repurchases of common stock(598)— — — — (94)— (94)
Stock-based compensation expense, tax benefit and issuance of common stock121 — 23 — — — — 23 
Balances at September 30, 202587,867 $8 $4,872 $(174)$4,044 $(4,736)$1,769 $5,783 
Common StockAdditional
Paid-In
Capital		Accumulated
Other
Comprehensive
Loss		Retained Earnings
(Accumulated
Deficit)		Treasury
Stock		Noncontrolling
Interests		Total Equity
Shares
Outstanding		Issued Par
Amount
Balances at December 31, 202399,950 $8 $4,834 $(181)$(192)$(2,861)$1,509 $3,117 
Net income— — — — 2,151 — 82 2,233 
Distributions paid to noncontrolling interests— — — — — — (78)(78)
Other comprehensive income— — — 2 — — — 2 
Net sales of businesses and noncontrolling interests— — (5)— — — (23)(28)
Repurchases of common stock(2,811)— — — — (280)— (280)
Stock-based compensation expense, tax benefit and issuance of common stock534 — (23)— — — — (23)
Balances at March 31, 202497,673 8 4,806 (179)1,959 (3,141)1,490 4,943 
Net income— — — — 259 — 97 356 
Distributions paid to noncontrolling interests— — — — — — (70)(70)
Other comprehensive income— — — 2 — — — 2 
Net purchases of businesses and noncontrolling interests— — 12 — — — 64 76 
Repurchases of common stock(1,990)— — — — (273)— (273)
Stock-based compensation expense, tax benefit and issuance of common stock136 — 22 — — — — 22 
Balances at June 30, 202495,819 8 4,840 (177)2,218 (3,414)1,581 5,056 
Net income— — — — 472 — 95 567 
Distributions paid to noncontrolling interests— — — — — — (79)(79)
Other comprehensive income— — — 2 — — — 2 
Accretion of redeemable noncontrolling interests— — (5)— — — — (5)
Net sales of businesses and noncontrolling interests— — (3)— — — (5)(8)
Repurchases of common stock(795)— — — — (124)— (124)
Stock-based compensation expense, tax benefit and issuance of common stock59 — 17 — — — — 17 
Balances at September 30, 202495,083 $8 $4,849 $(175)$2,690 $(3,538)$1,592 $5,426 
Schedule of Changes in Redeemable Noncontrolling Interests in Equity of Consolidated Subsidiaries
The table below presents our nonredeemable noncontrolling interests balances by segment:
 September 30, 2025December 31, 2024
Hospital Operations$204 $205 
Ambulatory Care1,565 1,444 
Total nonredeemable noncontrolling interests$1,769 $1,649 
The table below presents our income available to nonredeemable noncontrolling interests by segment:
 Three Months Ended
September 30,		Nine Months Ended
September 30,
 2025202420252024
Hospital Operations$9 $14 $33 $35 
Ambulatory Care97 81 273 239 
Total net income available to nonredeemable noncontrolling interests
$106 $95 $306 $274 
Schedule of Share Repurchase Activity
The table below presents repurchase activity under both the 2022 and 2024 share repurchase programs:
PeriodTotal Number of Shares PurchasedAverage Price Paid per ShareTotal Number of Shares Purchased as Part of Publicly Announced ProgramMaximum Dollar Value of Shares That May Yet Be Purchased Under the Program
 (In Thousands)(In Thousands)(In Millions)
Nine Months Ended September 30, 2025:
January 1 through January 31, 2025—$— —$1,376 
February 1 through February 28, 20251,800$134.98 1,800$1,133 
March 1 through March 31, 2025829$126.67 829$1,028 
April 1 through April 30, 2025—$— —$1,028 
May 1 through May 31, 20252,456$157.57 2,456$641 
June 1 through June 30, 20252,145$167.83 2,145$281 
July 1 through July 31, 2025598$155.43 598$1,688 
August 1 through August 31, 2025—$— —$1,688 
September 1 through September 30, 2025—$— —$1,688 
January 1 through September 30, 20257,828$151.75 7,828
Nine Months Ended September 30, 2024:
January 1 through January 31, 2024—$— —$550 
February 1 through February 29, 2024—$— —$550 
March 1 through March 31, 20242,811$98.86 2,811$272 
April 1 through April 30, 2024—$— —$272 
May 1 through May 31, 2024—$— —$272 
June 1 through June 30, 20241,990$135.85 1,990$2 
July 1 through July 31, 2024—$— —$1,500 
August 1 through August 31, 2024—$— —$1,500 
September 1 through September 30, 2024795$155.95 795$1,376 
January 1 through September 30, 20245,596$120.07 5,596